3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
7
Observational
2
Sponsor
Conditions
Arthritis, Rheumatoid
2
Interventions
Surveys and Questionnaires
286
Blood Specimen Collection
145
Gene Expression Profiling
96
Interviews as Topic
83
Immunohistochemistry
78
Polymerase Chain Reaction
64
Surgical Procedures, Operative
62
Magnetic Resonance Spectroscopy
59
Microarray Analysis
55
Flow Cytometry
53
Radiotherapy
49
Amplified Fragment Length Polymorphism Analysis
48
Drug Therapy
46
Observation
45
Biopsy
42
Bevacizumab
40
Reverse Transcriptase Polymerase Chain Reaction
39
Data Collection
35
Sorafenib
29
Psychiatric Rehabilitation
29
Nivolumab
28
palbociclib
26
In Situ Hybridization, Fluorescence
26
Rituximab
25
Hepatectomy
25
Therapeutics
24
Neoadjuvant Therapy
24
Docetaxel
24
Colonoscopy
24
Sunitinib
23
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Observational
×
Certolizumab Pegol
×
Clear all
NCT04798287
2022-06-22
STAR-RA-Cancer
Brigham and Women's Hospital
Completed
105,711 enrolled
NCT02778789
2019-09-26
Re-Bone
University of Erlangen-Nürnberg Medical School
Completed
66 enrolled